LL37, a human antimicrobial peptide with immunomodulatory properties

Cationic antimicrobial peptides (AMPs) represent the first line of defense against many invading pathogens. These small amphipathic peptides are part of the innate immune system and have a broad-spectrum activity against bacteria, fungi and viruses. In mammals, at least two distinct groups of AMPs are found. Defensins are the more representatives and cathelicidins form the second group. The hCAP18/LL37 is the only known human cathelicidin. The antimicrobial peptide is referred to as LL37, since it has a 37 amino acids sequence starting with two leucines. It is a 4.5 kDa, cationic (+6), amphipathic α-helical peptide, with a broad spectrum of antimicrobial activity. Besides its antimicrobial properties LL37 plays a central role in innate immune responses and inflammation. It has been identified as a potent chemoattractant for mast cells, monocytes, T lymphocytes and neutrophils using formyl-peptide receptor–like 1 (FPRL1). LL37 also promotes wound healing, angiogenesis and arteriogenesis and acts as immune adjuvant.